Ozone Autohemotherapy for Ischemic Stroke Sleep Disorder

Mengmeng Chen

Status: Not yet enrolling

Conditions: Post-ischemic Stroke Insomnia

Treatments: Other: ozone autohemotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT05508113

2022100

Details and patient eligibility

About

The purpose of this study is to observe the efficacy and safety of ozonated autohemotherapy in patients of post-ischemic stroke insomnia and to explore its mechanism of action.

Enrollment: 60 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• meet the diagnostic criteria for ischemic stroke; Insomnia quality index (ISI) score > 7 points

Exclusion criteria

• acute ischemic stroke; associated with failure of important organs or malignant tumor; patients with worsening condition, new cerebral infarction or secondary cerebral hemorrhage; with comprehension or cognitive impairment, unable to fully understand the scale and unable to cooperate with treatment

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

Control

No Intervention group

Description:

No intervention was given to this group of patients

20-40ug/ml ozone

Experimental group

Description:

ozone autohemotherapy

Treatment:

Other: ozone autohemotherapy